Satsuma Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Satsuma Pharmaceuticals

07/11/2022 22:06

* Satsuma Pharmaceuticals Inc  STSA.OQ  reported a quarterly
adjusted loss of 48 cents​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of 54 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Satsuma Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 48 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.6%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Satsuma Pharmaceuticals Inc shares had fallen by 25.2%
this
quarter and lost 0.2% so far this year.
    * The company reported a quarterly loss of $15.14 million.
    * Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 10:06 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.54          -0.48          Beat
 Jun. 30 2022      -0.49          -0.52          Missed
 Mar. 31 2022      -0.49          -0.49          Met
 Dec. 31 2021      -0.48          -0.49          Missed